What studies exist on GLP-1 receptor agonist medications and their effects on addiction, including smoking, drugs, and alcohol?

Evidence shows that GLP-1 receptor agonists may reduce consumption and cravings related to alcohol, tobacco, and a variety of other substance use disorders, though more high-quality trials are needed to confirm these findings.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-19
DOI
https://doi.org/10.5281/zenodo.24366476
Primary Topic
Substance Abuse Treatment and Outcomes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

What studies exist on GLP-1 receptor agonist medications and their effects on addiction, including smoking, drugs, and alcohol?

Tripdatabase
Zenodo (CERN European Organization for Nuclear Research)
Substance Abuse Treatment and Outcomes
article

What studies exist on GLP-1 receptor agonist medications and their effects on addiction, including smoking, drugs, and alcohol?

Tripdatabase
article en

Abstract

Evidence shows that GLP-1 receptor agonists may reduce consumption and cravings related to alcohol, tobacco, and a variety of other substance use disorders, though more high-quality trials are needed to confirm these findings.

Zenodo (CERN European Organization for Nuclear Research)
Substance Abuse Treatment and Outcomes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon